Brief: Kuros Biosciences H1 Net Loss Widens To CHF 5.8 Million

Kuros Biosciences AG

12/08/2020 06:09

Aug 12 (Reuters) - Kuros Biosciences AG  KURN.S :
    * H1 REVENUES INCREASED TO CHF 1.3 MILLION DRIVEN BY STRONG
MAGNETOS SALES, UP 42% VERSUS H1 2019
    * H1 NET OPERATING COSTS AMOUNTED TO CHF 7.5 MILLION (FIRST
HALF
2019: CHF 6.1 MILLION)
    * H1 NET LOSS FOR SIX MONTHS ENDED JUNE 30, 2020 AMOUNTED TO
CHF
5.8 MILLION (FIRST HALF 2019: CHF 5.2 MILLION)
    * OUTLOOK 2020: BELIEVES IT REMAINS WELL PLACED TO GROW ITS
REVENUES

Source text for Eikon:  ID:nTENtr937a 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))